WENDY LANDRIGAN: Open Payments
NPI 1316903495 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 75 payments from 17 companies in 2025. Trend: 2023 $944 · 2024 $919 · 2025 $1,347
Food & beverage: $1,347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $497 |
| Janssen Biotech, Inc. | 11 | $170 |
| Aimmune Therapeutics, Inc. | 4 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Intercept Pharmaceuticals, Inc. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Celltrion USA Inc. | 3 | $47 |
| QOL Medical, LLC | 3 | $47 |
| PFIZER INC. | 3 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
Products named: TREMFYA, RINVOQ, MAVYRET, SKYRIZI, VOWST, OCALIVA, DUPIXENT, VEGZELMA.
Industry payments across NC — which companies pay providers there.
